SYDNEY -- Parkinson's disease patients who have impaired cognition appeared to benefit from the Alzheimer's disease medicine donepezil (Aricept) -- with no detriment to their motor skills, researchers ...

GENEVA, SWITZERLAND (4 APRIL 2002) - Results from the first head-to-head study comparing ARICEPT® (donepezil HCl tablets) and Reminyl® (galantamine HBr tablets) demonstrated significantly greater ...

The FDA approval of 23-mg donepezil (Aricept) conflicted with the opinions of its own reviewers and breached the agency’s own regulatory standard, authors write in a BMJ article, leading to misleading ...

The prescribed dosage for Aricept (donepezil) may depend on a person’s individual treatment plan. Factors such as the person’s medical history and condition may affect the dosage of Aricept. Aricept ...

Aricept (donepezil) is a prescription drug used to treat dementia related to Alzheimer’s disease. Aricept belongs to a class of drugs called acetylcholinesterase inhibitors. It is not an antipsychotic ...

New warnings have been added to the prescribing information for the Alzheimer's drug Aricept (donepezil) advising of the risk of two rare but potentially serious conditions: muscle breakdown ...

Public Citizen asked the FDA to ban high-dose Aricept because of side effects. May 19, 2011— -- Public Citizen has petitioned the Food and Drug Administration to ban high doses of the Alzheimer's ...

This follows the very first approval of Aricept for DLB in Japan in September 2014, making the Philippines only the second country in which Aricept has gained this license. An application seeking ...

Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study Adult female BCS exposed to ≥4 cycles of adjuvant ...

Eleven people died in a clinical trial of Eisai's Alzheimer's therapy Aricept for vascular dementia compared to no deaths in the control group. But Eisai noted that it was unusual to see such a low ...